Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...